RZLV stock has collapsed 67% from its 52-week high — yet Wall Street’s average price target sits at $10.75, implying more than 270% upside. RZLV stock is trading at $2.77 with a Strong Buy consensus and an average $10.75 price target; we rate Rezolve AI a Buy on a high-risk/high-reward basis, driven by a 23x revenue ramp, a $232M contracted 2026 revenue backlog, and an ongoing tactical M&A push. Rezolve AI PLC (NASDAQ: RZLV) reported 2025 GAAP revenue of $46.8 million — up from $2.01 million a year earlier — and has now raised its 2026 revenue guidance to $360 million. This RZLV stock price analysis examines whether the Street’s bullish targets are credible given the stock’s steep drawdown and the unresolved Commerce.com merger battle.
Key Stock Data: Rezolve AI (RZLV)
| Metric | Value |
| Current Price | $2.77 |
| 52-Week Range | $1.30 – $8.45 |
| Drawdown from 52-wk High | -67.2% |
| Market Cap | ~$1.1 billion |
| 2025 Revenue | $46.8 million |
| 2026 Revenue Guide | $360 million |
| Contracted 2026 Revenue | $232 million |
| Analyst Consensus | Strong Buy |
| Average Price Target | $10.75 |
Table of Contents
- Key Stock Data: Rezolve AI (RZLV)
- Key Takeaways on RZLV Stock
- What Is Rezolve AI?
- Recent RZLV Stock Performance
- Commerce.com Merger and Poison Pill Battle
- RZLV Valuation Analysis 2026
- Bullish and Bearish Analyst Opinions on Rezolve AI
- Analyst Price Targets for RZLV Stock
- Frequently Asked Questions
Key Takeaways on RZLV Stock
- Price & verdict: RZLV trades at $2.77 with Strong Buy consensus and a $10.75 average price target — implying roughly 290% upside if the growth trajectory continues.
- Key stat: 2025 revenue of $46.8M represents a 23x year-over-year ramp from $2.01M, with $232M of 2026 revenue already contracted.
- Bull case: $360M 2026 revenue guide anchored by $232M in committed contracts; $500M+ ARR exit target; Strong Buy rating from 67% of analysts.
- Bear case: Stock down 67% from 52-week high of $8.45; ongoing Commerce.com merger creates dilution and execution uncertainty.
- Catalysts: Commerce.com shareholder vote (May 2026), first quarterly revenue print as a reporting company, further AI-commerce contract wins.
What Is Rezolve AI?
Rezolve AI PLC is a UK-headquartered generative-AI software company listed on Nasdaq under the ticker RZLV that builds retail and e-commerce solutions for brands and retailers. The company’s flagship platform, Brain Suite, delivers conversational AI-driven commerce, assisted shopping, personalised product discovery, and revenue-optimization tools for enterprise retailers across the United Kingdom, the United States, and select European markets. The current RZLV stock price reflects a sharp re-rating lower in 2026 despite a materially accelerating revenue ramp — a disconnect that explains the unusually bullish Street consensus.
Rezolve AI PLC (formerly Rezolve AI Limited, renamed in March 2025) went public via a SPAC transaction in 2024 and has since transitioned from pre-revenue software startup to a scaling enterprise-AI vendor in less than 18 months. The company reports revenue from three product lines: Brain Commerce (AI-powered checkout and assisted shopping), Brain Assistant (merchandising copilots), and Brain Checkout (headless conversational commerce APIs). Management has consistently emphasised that more than half of 2025’s revenue is recurring in nature, giving RZLV a far stronger quality-of-earnings profile than most post-SPAC AI names.
Recent RZLV Stock Performance
RZLV has been one of the most volatile names in the post-SPAC AI cohort. The stock reached a 52-week high of $8.45 in September 2025 on enthusiasm for the Brain Suite launch and a series of Tier-1 retailer pilots. It subsequently declined more than 67% over the next six months as SPAC-era lockups expired, macro AI sentiment moderated, and execution risks around the Commerce.com bid overwhelmed the positive operational story. As of mid-April 2026, shares have stabilised in the $2.63–$2.78 zone, with trading volumes suggesting institutional accumulation at current levels.
In the most recent full-year 2025 earnings release on March 30, 2026, RZLV rallied 30% intraday before fading back, as investors took profits ahead of the Commerce.com shareholder vote. The 2025 results were well above the Street’s base-case revenue expectations, but guidance execution risk — specifically, converting the $232M contracted backlog to recognised GAAP revenue — remains the key operational debate heading into the remainder of 2026. Short interest on RZLV has expanded meaningfully since the 52-week high, standing at approximately 9% of float, which creates additional upside torque on any positive catalyst surprise.
Relative to other AI-infrastructure and AI-applications peers, RZLV has materially underperformed over the past six months. Benchmark names such as Palantir stock price and Salesforce stock price have held more of their 2025 gains thanks to their established enterprise revenue bases, whereas post-SPAC names like RZLV have borne the brunt of the AI-sentiment reset. The relative discount makes RZLV an unusual combination of high growth and low valuation that quantitative screens rarely surface.
Commerce.com Merger and Poison Pill Battle
The single biggest active-situation overhang on RZLV stock is the contested Commerce.com (NYSE: CMRC) merger. On April 8, 2026, Rezolve AI formally proposed an all-stock combination in which Commerce.com shareholders would receive one RZLV share for every two Commerce.com shares. At the time of the proposal, the implied exchange value was $1.44 per CMRC share — a 47% discount to CMRC’s $2.51 closing price that day, but one that Rezolve AI argued is appropriate because Commerce.com stock sits within 4% of its 52-week low and has fallen 51% over the prior twelve months.
Commerce.com’s board rejected the offer on April 11, 2026, and adopted a shareholder rights plan (“poison pill”) effective immediately and set to expire April 12, 2027. The poison pill is triggered if any single shareholder acquires 15% or more of Commerce.com’s outstanding stock. Rezolve AI responded publicly on April 14, 2026, labelling the poison pill a “desperate” entrenchment tactic and pressing its merger argument by highlighting RZLV’s Wall Street consensus target of $11.00 and contracted 2026 revenue of $232 million.
For RZLV shareholders, the merger introduces a real near-term uncertainty but also significant strategic upside if it succeeds. A combined entity would consolidate two AI-commerce platforms, eliminate duplicative corporate overhead, and create a cross-sell revenue synergy worth an estimated $40–$70 million annually. If the Commerce.com shareholder vote fails, RZLV retains its standalone growth thesis; if the merger goes through, the combined equity would have enhanced scale, though new-share issuance would temper the near-term per-share valuation. The May 2026 Commerce.com shareholder meeting is the single most important catalyst to track.
RZLV Valuation Analysis 2026
RZLV’s valuation looks dramatically different depending on which revenue base an investor uses. On 2025 GAAP revenue of $46.8 million, the stock trades at roughly 23x TTM sales — an elevated multiple on a historical-accounting basis. On management’s 2026 revenue guide of $360 million, the stock trades at approximately 3.1x forward sales — well below the median 6–9x forward-sales multiple of scaling AI-software peers. This guidance-based multiple is what creates the Street’s bullish stance.
| Valuation Metric | RZLV (2026E) | AI-Software Peer Avg |
| Price / TTM Sales | 23x | 19x |
| Price / FY2026E Sales | 3.1x | 8.5x |
| Revenue Growth YoY | ~670% | ~28% |
| Rule of 40 (rev growth + margin) | >100% | ~36% |
| Gross Margin | ~65% | ~72% |
The central valuation debate is binary: if RZLV executes against its $360 million guide, the forward multiple expands into the 6–10x range of peer AI-software names, which would imply a stock price of $5.50–$9.00 by mid-2027. If RZLV misses the guide by more than 25%, forward multiple compression would bring the equity down toward $1.50–$2.00 — not far below current levels. The asymmetric payoff profile is what supports the Strong Buy consensus: the downside from the current quote is limited by already-contracted revenue, while the upside is supported by the discount to AI-software peer multiples.
A second useful lens is enterprise-value to contracted-revenue. With $232 million of 2026 revenue already under contract and a market cap of approximately $1.1 billion, RZLV trades at 4.7x already-committed 2026 revenue. That is roughly half the multiple applied to comparable contracted-revenue names like Salesforce stock price — and assumes zero credit for the $128 million of additional 2026 revenue within the full-year guide but not yet contracted. This structural discount is what attracted sell-side analysts to the name after the Q4 2025 earnings print.
Bullish and Bearish Analyst Opinions on Rezolve AI
Sell-side sentiment on RZLV is among the most concentrated on Nasdaq’s post-SPAC AI cohort — 67% of covering analysts have a Strong Buy rating, 33% a Buy, and 0% Hold or Sell. That unusually clean split reflects the combination of strong execution (the 23x revenue ramp), a discounted forward multiple, and the upside optionality of the Commerce.com combination. The table below summarises the key bull and bear arguments on the stock.
| Bull Case Drivers | Bear Case Concerns |
| 2025 revenue up 23x YoY to $46.8M — fastest-growing AI-commerce story | Stock down 67% from 52-week high — momentum deterioration concern |
| $232M of 2026 revenue already contracted — 65% of full-year guide | Commerce.com merger path uncertain — poison pill and shareholder vote |
| Strong Buy consensus — 67% of analysts; $10.75 average target | Lockup expirations and post-SPAC overhang continue to weigh on equity |
| Forward P/S of 3.1x vs peer average of 8.5x — structural discount | Guide execution risk — converting backlog to GAAP revenue is non-trivial |
| Short interest at ~9% of float — meaningful short-cover potential | Gross margin below peer median — scale investments still weighing |
The bull and bear debate on RZLV essentially resolves to one question: does the $360 million 2026 guide get delivered, in line, below, or above? At 65% of the guide already under contract, the bull case argues that the remaining 35% is highly achievable, particularly given the pipeline disclosed in the company’s March 2026 investor deck. The bear view is that post-SPAC AI companies have a structural track record of missing guide, and that $360M represents an 7.7x jump from $46.8M — a ramp few enterprise-software companies have delivered cleanly in a single year.
Analyst Price Targets for RZLV Stock
Analyst price targets on RZLV range from $7 at the low end to $15 at the high end, with an average of $10.75 and a median of $10.25 — implying roughly 290% upside from the current $2.77 level. The tight clustering of targets around $10 reflects consensus that the stock is meaningfully undervalued against forward revenue, while the wide range acknowledges the Commerce.com merger and guide-execution uncertainties.
| Firm | Rating | Price Target |
| H.C. Wainwright | Buy | $15 |
| Chardan Capital | Buy | $12 |
| Roth Capital | Buy | $11 |
| Needham & Co. | Buy | $10 |
| Benchmark | Buy | $7 |
| Consensus (6 analysts) | Strong Buy | $10.75 |
The most likely catalysts that could drive target revisions higher include a constructive outcome to the Commerce.com shareholder vote, a Q1 2026 revenue print in line with or above the $75–$80M implied quarterly run-rate, and announcement of new Tier-1 retailer contracts in the U.S. and EU. Conversely, a guide cut, a failed merger combined with loss of strategic optionality, or additional dilutive SPAC-legacy share issuance would likely trigger downward target revisions.
For investors weighing a position, RZLV represents a high-risk/high-reward play on AI-commerce. The combination of triple-digit revenue growth, a deeply discounted forward multiple, and unusually aligned Street sentiment creates a set-up that rewards patience. Traders should, however, size positions against the drawdown risk — 67% from the 52-week high shows how quickly sentiment can unwind in post-SPAC AI equities when growth execution slips or macro liquidity tightens.
Frequently Asked Questions
Is RZLV stock a good buy in 2026?
RZLV has a Strong Buy consensus with a $10.75 average price target — implying roughly 290% upside from $2.77. The investment case rests on delivering the $360 million 2026 revenue guide, of which $232 million is already under contract. Best viewed as a high-risk/high-reward AI-commerce play.
Why did RZLV stock drop 67% from its high?
The decline reflects a combination of post-SPAC lockup expirations, a broader 2026 reset in AI-software sentiment, and uncertainty around the Commerce.com merger. The fundamentals improved throughout 2025, which is why the Street consensus points to substantial upside from current levels.
What is Rezolve AI’s Commerce.com merger about?
Rezolve AI proposed a 1-for-2 share exchange for Commerce.com (CMRC) shares on April 8, 2026. Commerce.com’s board rejected the offer and adopted a poison pill. The Commerce.com shareholder vote in May 2026 is the key near-term catalyst that will determine whether the merger progresses.
What is Rezolve AI’s 2026 revenue guidance?
Rezolve AI has guided 2026 revenue to $360 million, with $232 million already under contract. The company is targeting a $500 million+ annual recurring revenue exit for 2026, which would represent a roughly 7.7x increase from 2025 GAAP revenue of $46.8 million.
How does RZLV compare to other AI software stocks?
RZLV trades at approximately 3.1x forward 2026 sales versus the AI-software peer average of 8.5x — a meaningful structural discount. Peers such as Palantir stock price and Salesforce stock price provide the benchmark multiple for AI-enabled enterprise-software names.
Disclaimer
This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell securities. Past performance does not guarantee future results. Investors should conduct thorough due diligence and consult qualified financial advisors before making investment decisions.
MEXC is a global cryptocurrency exchange committed to “MEXCmize Your Opportunities.” Serving over 40 million users across 170+ countries, MEXC offers access to more than 3,000 digital assets across spot and derivatives markets. Known for its high liquidity and broad selection of trending tokens, the platform is designed to support both new traders and experienced investors. MEXC also continues to enhance trading efficiency through innovations such as zero trading fees, while prioritizing a secure, user-friendly, and accessible trading experience. Select MEXC as Your 0-fee Gateway To Infinite Opportunities.
